Enterprise Stent Aneurysm Treatment (ESAT) Study - France

NCT00879580 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 133

Last updated 2013-10-11

No results posted yet for this study

Summary

The purpose of this study is to evaluate the morbidity, mortality, and efficacy of use of the Enterprise(TM) stent for the treatment of (ruptured or non-ruptured) intracranial aneurysms.

Conditions

  • Intracranial Aneurysm

Sponsors & Collaborators

  • Codman & Shurtleff

    lead INDUSTRY

Principal Investigators

  • Jonathan Megerian, MD, PhD · Codman & Shurtleff

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00879580 on ClinicalTrials.gov